PMID: 3214483Nov 1, 1988Paper

Effects of cessation of smoking on serum lipids and high density lipoprotein-cholesterol

Atherosclerosis
R J Moffatt

Abstract

This study examined the effect of cessation of smoking on serum lipid and lipoprotein levels. Twenty-six females who smoked a minimum of 20 cigarettes per day for the past 5 years served as volunteers. Twelve subjects abstained from smoking for a period of 60 days (ex-smokers). Six stopped smoking for 30 days then resumed smoking for an additional 30 days (re-smokers). Eight subjects continued to smoke for the entire 60 days (smokers). Additionally, 10 females who had never smoked served as non-smoking controls (non-smokers). Pre-cessation HDL-C levels for all smoker groups were 15-20% (P less than 0.05) below those of non-smokers. By day 30 of cessation HDL-C levels of ex-smokers and re-smokers significantly increased by 5.7 and 10.5 mg/dl, respectively, and were significantly higher than those of smokers. At day 60, HDL-C of ex-smokers increased another 6.8 mg/dl to 63.9 mg/dl while levels of re-smokers returned to pre-cessation levels (50.7 mg/dl). The findings of this study suggest that low levels of HDL-C associated with smoking in females do not appear to be cumulative and can be reversed in as little as 30 days.

References

Feb 5, 1976·The New England Journal of Medicine·G G RhoadsA Kagan
May 1, 1978·Atherosclerosis·R J GarrisonS J Padgett
Nov 1, 1979·Atherosclerosis·K BergG Dahlen
Dec 1, 1990·Baillière's Clinical Endocrinology and Metabolism·M F Laker, F L Game
Jan 15, 1982·Biochemical and Biophysical Research Communications·K M HegartyJ L Hojnacki

❮ Previous
Next ❯

Citations

Aug 1, 1990·Clinical Cardiology·R F Leighton
Dec 1, 1992·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·D GallagherR de Meersman
Jun 6, 2003·Journal of Ethnopharmacology·A Al-ZubairiA Al-Geiry
Dec 15, 2000·European Journal of Clinical Investigation·F W van den BerkmortelA F Stalenhoef
Feb 10, 2004·Cardiology in Review·Christine E YoungJeffrey T Kuvin
Feb 24, 2006·Journal of Cardiovascular Pharmacology·Jeffrey T KuvinRichard H Karas
Jul 17, 2008·Vascular Health and Risk Management·Navin K KapurRoger S Blumenthal
Feb 11, 2009·Current Medical Research and Opinion·Ivan Berlin
Mar 27, 2010·Journal of the American College of Cardiology·Pradeep NatarajanChristopher P Cannon
Nov 21, 2013·Biomarker Research·Barbara A ForeyKatharine J Coombs
Mar 1, 1992·Preventive Medicine·D StricklandH Lando
Nov 1, 2005·Future Cardiology·Karam M Kostner, Edmund Cauza
Jan 29, 2003·Circulation·Sashi GuthikondaWilliam G Haynes
Sep 19, 1998·Medicine and Science in Sports and Exercise·R NiauraD Abrams
Dec 24, 2013·Journal of Cardiovascular Pharmacology and Therapeutics·William E BodenPeter P Toth
Feb 13, 2007·The Journal of Cardiovascular Nursing·Lynne T Braun
Jan 1, 1997·The Annals of Pharmacotherapy·V M Wilt, J G Gums
May 1, 1995·Annals of Clinical Biochemistry·K Evans, M F Laker
Dec 23, 2009·Current Medical Research and Opinion·Ivan Berlin
Mar 11, 2021·Global Health & Medicine·Hidekatsu Yanai, Hiroshi Yoshida
Sep 1, 1993·Metabolism: Clinical and Experimental·D N BrindleyE C Suarez
May 4, 2004·Atherosclerosis. Supplements·Philip Barter
Dec 1, 1995·Metabolism: Clinical and Experimental·R J MoffattK D Biggerstaff
Jun 1, 1997·Metabolism: Clinical and Experimental·F RichardP Amouyel
Aug 1, 1994·Disease-a-month : DM·R S RosensonC C Tangney

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.